NASDAQ:PRPO PRECIPIO INC. Starting to trade up on today’s news. Halted up 20% as of writing this.

Precipio Signs First IV-Cell Customer Agreement

GlobeNewswire   “Press Releases”

NEW HAVEN, Conn., May 10, 2022 (GLOBE NEWSWIRE) — Specialty cancer diagnostics company.(NASDAQ:PRPO), announced today that (AON) of Fort Myers, Florida, has completed its validation of Precipios proprietary IV-Cell culture media, and will adopt the product for use in its clinical cytogenetics laboratory.

The adoption of IV-Cell by industry leader AON demonstrates Precipios ability to identify a critical unmet market need, develop and bring to market a differentiated, high value solution to the customer. Previous launch of HemeScreen testing by AON in, combined with this agreement for IV-Cell serve as validation of Precipios new strategic business model as a specialty cancer diagnostics products company, and its ability to deliver multiple products to the same customer.

Read the entire article: https://www.globenewswire.com/news-release/2022/05/10/2439957/0/en/Precipio-Signs-First-IV-Cell-Customer-Agreement.html

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.